[ad_1]
Second-quarter earnings jump 54% to $20.7 million as Chicago company adds 11 dispensaries to its network.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...